A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including ...